Logothetis CJ - Search Results

1

The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.

He Y, Gu J, Strom S, Logothetis CJ, Kim J, Wu X. He Y, et al. Among authors: logothetis cj. Clin Cancer Res. 2014 Oct 1;20(19):5133-5139. doi: 10.1158/1078-0432.CCR-14-0661. Clin Cancer Res. 2014. PMID: 25274378 Free PMC article.

2

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

3

Serum calcitonin in small cell carcinoma of the prostate.

Sim SJ, Glassman AB, Ro JY, Lee JJ, Logothetis CJ, Liu FJ. Sim SJ, et al. Among authors: logothetis cj. Ann Clin Lab Sci. 1996 Nov-Dec;26(6):487-95. Ann Clin Lab Sci. 1996. PMID: 8908318

4

Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancer.

Tu SM, Pagliaro LC, Banks ME, Amato RJ, Millikan RE, Bugazia NA, Madden T, Newman RA, Logothetis CJ. Tu SM, et al. Among authors: logothetis cj. Clin Cancer Res. 1998 May;4(5):1193-201. Clin Cancer Res. 1998. PMID: 9607577 Clinical Trial.

5

Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer.

Ellerhorst JA, Tu SM, Amato RJ, Finn L, Millikan RE, Pagliaro LC, Jackson A, Logothetis CJ. Ellerhorst JA, et al. Among authors: logothetis cj. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2371-6. Clin Cancer Res. 1997. PMID: 9815636 Clinical Trial.

6

Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2493-500. Clin Cancer Res. 1997. PMID: 9815652

7

Aneuploidy index in blood: a potential marker for early onset, androgen response, and metastasis in human prostate cancer.

Ozen M, Hopwood VL, Johnston DA, Babaian RJ, Logothetis CJ, von Eschenbach AC, Pathak S. Ozen M, et al. Among authors: logothetis cj. Urology. 1999 Feb;53(2):381-5. doi: 10.1016/s0090-4295(98)00487-7. Urology. 1999. PMID: 9933059

8

Serologic tumor markers, clinical biology, and therapy of prostatic carcinoma.

Kim J, Logothetis CJ. Kim J, et al. Among authors: logothetis cj. Urol Clin North Am. 1999 May;26(2):281-90. doi: 10.1016/s0094-0143(05)70068-9. Urol Clin North Am. 1999. PMID: 10361551 Review.

9

Brain metastasis from prostate carcinoma: antemortem recognition and outcome after treatment.

McCutcheon IE, Eng DY, Logothetis CJ. McCutcheon IE, et al. Among authors: logothetis cj. Cancer. 1999 Dec 1;86(11):2301-11. doi: 10.1002/(sici)1097-0142(19991201)86:11<2301::aid-cncr18>3.0.co;2-d. Cancer. 1999. PMID: 10590371

10

TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.

Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. Clin Cancer Res. 2000 Mar;6(3):1190-7. Clin Cancer Res. 2000. PMID: 10741751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters